Bruker Announces Agreement to Acquire Neurescence Inc., Bolstering Neuroscience Research Portfolio
Delivers Simultaneous Multi-Region Neural Imaging of Free-Behaving Animals BILLERICA, Mass.–(BUSINESS WIRE)– Bruker Corporation (Nasdaq: BRKR) today announced the signing of the definitive agreement to purchase 100% of the shares of Neurescence Inc., an innovative provider of ultralight fiber-bundle Multiscopes™ for simultaneous multi-region, optical functional neuroimaging. Neurescence’s flagship product Chromatone™ moves illumination and detection hardware off... Read more
Bruker Announces Quarterly Dividend
BILLERICA, Mass–(BUSINESS WIRE)– Bruker Corporation (Nasdaq: BRKR) today announced that its Board of Directors has approved payment of a quarterly cash dividend in the amount of $0.05 per share on the Company’s common stock. The dividend will be paid on December 16, 2022 to stockholders of record as of December 1, 2022. About Bruker Corporation... Read more